Skip to main content
Thank you for visiting nature.com. You are using a browser version
with limited support for CSS. To obtain the best experience, we
recommend you use a more up to date browser (or turn off
compatibility mode in Internet Explorer). In the meantime, to
ensure continued support, we are displaying the site without styles
and JavaScript.
Advertisement
[image]
[image]
•  View all journals
•  
Search
•  Log in
•  Content Explore content
•  About the journal
•  Publish with us
•  Subscribe
•  Sign up for alerts
•  RSS feed
1. nature 
2. cell death & differentiation 
3. original paper 
4. article
Show authors
•  Original Paper
•  Published: 25 April 2014


ARHI (DIRAS3) induces
autophagy in ovarian cancer
cells by downregulating the
epidermal growth factor
receptor, inhibiting PI3K and
Ras/MAP signaling and
activating the FOXo3a-
mediated induction of Rab7
•  Z Lu1,
•  H Yang1,
•  M N Sutton1,
•  M Yang1,
•  C H Clarke1,
•  W S-L Liao1 na1 &
•  …
•  R C Bast Jr
1 na1 
Cell Death & Differentiation volume 21, pages 1275–1289
(2014)Cite this article
•  4898 Accesses
•  76 Citations
•  Metrics details
Subjects
•  Autophagy
•  Cell signalling
•  Ovarian cancer


Abstract
The process of autophagy has been described in detail at the
molecular level in normal cells, but less is known of its regulation in
cancer cells. Aplasia Ras homolog member I (ARHI; DIRAS3) is an
imprinted tumor suppressor gene that is downregulated in multiple
malignancies including ovarian cancer. Re-expression of ARHI slows
proliferation, inhibits motility, induces autophagy and produces
tumor dormancy. Our previous studies have implicated autophagy
in the survival of dormant ovarian cancer cells and have shown that
ARHI is required for autophagy induced by starvation or rapamycin
treatment. Re-expression of ARHI in ovarian cancer cells blocks
signaling through the PI3K and Ras/MAP pathways, which, in turn,
downregulates mTOR and initiates autophagy. Here we show that
ARHI is required for autophagy-meditated cancer cell arrest and
ARHI inhibits signaling through PI3K/AKT and Ras/MAP by
enhancing internalization and degradation of the epidermal growth
factor receptor. ARHI-mediated downregulation of PI3K/AKT and
Ras/ERK signaling also decreases phosphorylation of FOXo3a,
which sequesters this transcription factor in the nucleus. Nuclear
retention of FOXo3a induces ATG4 and MAP-LC3-I, required for
maturation of autophagosomes, and also increases the expression of
Rab7, required for fusion of autophagosomes with lysosomes.
Following the knockdown of FOXo3a or Rab7, autophagolysosome
formation was observed but was markedly inhibited, resulting in
numerous enlarged autophagosomes. ARHI expression correlates
with LC3 expression and FOXo3a nuclear localization in surgical
specimens of ovarian cancer. Thus, ARHI contributes to the
induction of autophagy through multiple mechanisms in ovarian
cancer cells.
Similar content being viewed by others
[image]
The roles of autophagy, ferroptosis and pyroptosis in
the anti-ovarian cancer mechanism of harmine and


their crosstalk
Article Open access 18 March 2024
[image]
Arsenic compound sensitizes homologous
recombination proficient ovarian cancer to PARP
inhibitors
Article Open access 22 September 2021
[image]
Ras drives malignancy through stem cell crosstalk
with the microenvironment
Article Open access 30 November 2022
Log in or create a free account to read this
content
Gain free access to this article, as well as selected content from this
journal and more on nature.com
 Access through your institution
or
 Sign in or create an account 
[image] Continue with Google 
[image] Continue with ORCiD 
Abbreviations
ARHI:


aplasia Ras homolog member I
LC3:
myosin-associated protein light chain 3
DOX:
doxycycline
TEM:
transmission electron microscopy
References
1. Cecconi F, Levine B . The role of autophagy in mammalian
development: cell makeover rather than cell death. Dev Cell
2008; 15: 344–357.
Article  CAS  PubMed Central  PubMed  Google Scholar 
2. Melendez A, Levine B . Autophagy in C. elegans. WormBook
2009; 24: 1–26.
Article  Google Scholar 
3. Rosen DG, Wang L, Jain AN, Lu KH, Luo RZ, Yu Y et al.
Expression of the tumor suppressor gene ARHI in epithelial
ovarian cancer is associated with increased expression of
p21WAF1/CIP1 and prolonged progression-free survival. Clin
Cancer Res 2004; 10: 6559–6566.
Article  CAS  PubMed  Google Scholar 
4. Yu Y, Xu F, Peng H, Fang X, Zhao S, Li Y et al. NOEY2
(ARHI), an imprinted putative tumor suppressor gene in
ovarian and breast carcinomas. Proc Natl Acad Sci USA 1999;
96: 214–219.
Article  CAS  PubMed  PubMed Central  Google Scholar 


5. Luo RZ, Fang X, Marquez R, Liu SY, Mills GB, Liao WS et al.
ARHI is a Ras-related small G-protein with a novel N-terminal
extension that inhibits growth of ovarian and breast cancers.
Oncogene 2003; 22: 2897–2909.
Article  CAS  PubMed  Google Scholar 
6. Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S et al. The tumor
suppressor gene ARHI regulates autophagy and tumor
dormancy in human ovarian cancer cells. J Clin Invest 2008;
118: 3917–3929.
CAS  PubMed  PubMed Central  Google Scholar 
7. Sengupta A, Molkentin JD, Yutzey KE . FoxO transcription
factors promote autophagy in cardiomyocytes. J Biol Chem
2009; 284: 28319–28331.
Article  CAS  PubMed Central  PubMed  Google Scholar 
8. Hofler A, Nichols T, Grant S, Lingardo L, Esposito EA, Gridley
S et al. Study of the PDK1/AKT signaling pathway using
selective PDK1 inhibitors, HCS, and enhanced biochemical
assays. Anal Biochem 2011; 414: 179–186.
Article  CAS  PubMed  Google Scholar 
9. Rosenberger G, Meien S, Kutsche K . Oncogenic HRAS
mutations cause prolonged PI3K signaling in response to
epidermal growth factor in fibroblasts of patients with
Costello syndrome. Hum Mutat 2009; 30: 352–362.
Article  CAS  PubMed  Google Scholar 
10. Gremer L, De Luca A, Merbitz-Zahradnik T, Dallapiccola B,
Morlot S, Tartaglia M et al. Duplication of Glu37 in the switch
I region of HRAS impairs effector/GAP binding and underlies
Costello syndrome by promoting enhanced growth factor-
dependent MAPK and AKT activation. Hum Mol Genet 2010;
19: 790–802.
Article  CAS  PubMed  Google Scholar 


11. Clague MJ . Met receptor: a moving target. Sci Signal 2011; 4:
pe40.
Article  PubMed  Google Scholar 
12. Jacob C, Cottrell GS, Gehringer D, Schmidlin F, Grady EF,
Bunnett NW . c-Cbl mediates ubiquitination, degradation, and
down-regulation of human protease-activated receptor 2. J
Biol Chem 2005; 280: 16076–16087.
Article  CAS  PubMed  Google Scholar 
13. Tanowitz M, von Zastrow M . A novel endocytic recycling
signal that distinguishes the membrane trafficking of
naturally occurring opioid receptors. J Biol Chem 2003; 278:
45978–45986.
Article  CAS  PubMed  Google Scholar 
14. Futter CE, Collinson LM, Backer JM, Hopkins CR . Human
VPS34 is required for internal vesicle formation within
multivesicular endosomes. J Cell Biol 2001; 155: 1251–1264.
Article  CAS  PubMed Central  PubMed  Google Scholar 
15. Miranda A, Mickle A, Medda B, Zhang Z, Phillips RJ, Tipnis N
et al. Altered mechanosensitive properties of vagal afferent
fibers innervating the stomach following gastric surgery in
rats. Neuroscience 2009; 162: 1299–1306.
Article  CAS  PubMed  Google Scholar 
16. Fang L, Wang H, Zhou L, Yu D . Akt-FOXO3a signaling axis
dysregulation in human oral squamous cell carcinoma and
potent efficacy of FOXO3a-targeted gene therapy. Oral Oncol
2011; 47: 16–21.
Article  PubMed  Google Scholar 
17. Chen J, Gomes AR, Monteiro LJ, Wong SY, Wu LH, Ng TT et
al. Constitutively nuclear FOXO3a localization predicts poor
survival and promotes Akt phosphorylation in breast cancer.


PLoS One 2010; 5: e12293.
Article  PubMed Central  PubMed  Google Scholar 
18. Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X et al.
ERK promotes tumorigenesis by inhibiting FOXO3a via
MDM2-mediated degradation. Nat Cell Biol 2008; 10: 138–
148.
Article  CAS  PubMed Central  PubMed  Google Scholar 
19. Hu MC, Lee DF, Xia W, Golfman LS, Ou-Yang F, Yang JY et al.
IkappaB kinase promotes tumorigenesis through inhibition of
forkhead FOXO3a. Cell 2004; 117: 225–237.
Article  CAS  PubMed  Google Scholar 
20. Plas DR, Thompson CB . Akt activation promotes degradation
of tuberin and FOXO3a via the proteasome. J Biol Chem 2003;
278: 12361–12366.
Article  CAS  PubMed  Google Scholar 
21. Jager S, Bucci C, Tanida I, Ueno T, Kominami E, Saftig P et al.
Role for Rab7 in maturation of late autophagic vacuoles. J
Cell Sci 2004; 117 (Part 20): 4837–4848.
Article  PubMed  Google Scholar 
22. Hariharan N, Maejima Y, Nakae J, Paik J, Depinho RA,
Sadoshima J . Deacetylation of FoxO by Sirt1 plays an
essential role in mediating starvation-induced autophagy in
cardiac myocytes. Circ Res 2010; 107: 1470–1482.
Article  CAS  PubMed Central  PubMed  Google Scholar 
23. Gutierrez MG, Munafo DB, Beron W, Colombo MI . Rab7 is
required for the normal progression of the autophagic
pathway in mammalian cells. J Cell Sci 2004; 117 (Part 13):
2687–2697.
Article  CAS  PubMed  Google Scholar 


24. Thi EP, Lambertz U, Reiner NE . Class IA phosphatidylinositol
3-kinase p110alpha regulates phagosome maturation. PLoS
One 2012; 7: e43668.
Article  CAS  PubMed Central  PubMed  Google Scholar 
25. Lawe DC, Patki V, Heller-Harrison R, Lambright D, Corvera S
. The FYVE domain of early endosome antigen 1 is required
for both phosphatidylinositol 3-phosphate and Rab5 binding.
Critical role of this dual interaction for endosomal
localization. J Biol Chem 2000; 275: 3699–3705.
Article  CAS  PubMed  Google Scholar 
26. Nazio F, Strappazzon F, Antonioli M, Bielli P, Cianfanelli V,
Bordi M et al. mTOR inhibits autophagy by controlling ULK1
ubiquitylation, self-association and function through AMBRA1
and TRAF6. Nat Cell Biol 2013; 15: 406–416.
Article  CAS  PubMed  Google Scholar 
27. Huang S, Yang ZJ, Yu C, Sinicrope FA . Inhibition of mTOR
kinase by AZD8055 can antagonize chemotherapy-induced
cell death through autophagy induction and down-regulation
of p62/sequestosome 1. J Biol Chem 2011; 286: 40002–
40012.
Article  CAS  PubMed Central  PubMed  Google Scholar 
28. Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J et al. ULK-
ATG13-FIP200 complexes mediate mTOR signaling to the
autophagy machinery. Mol Biol Cell 2009; 20: 1992–2003.
Article  CAS  PubMed Central  PubMed  Google Scholar 
29. Su H, Gu Y, Li F, Wang Q, Huang B, Jin X et al. The PI3K/
AKT/mTOR signaling pathway is overactivated in primary
aldosteronism. PLoS One 2013; 8: e62399.
Article  CAS  PubMed Central  PubMed  Google Scholar 
30. Chen J, Crawford R, Xiao Y . Vertical inhibition of the PI3K/


Akt/mTOR pathway for the treatment of osteoarthritis. J Cell
Biochem 2013; 114: 245–249.
Article  CAS  PubMed  Google Scholar 
31. Hara T, Takamura A, Kishi C, Iemura S, Natsume T, Guan JL
et al. FIP200, a ULK-interacting protein, is required for
autophagosome formation in mammalian cells. J Cell Biol
2008; 181: 497–510.
Article  CAS  PubMed Central  PubMed  Google Scholar 
32. Zhou WJ, Deng R, Feng GK, Zhu XF . [A G-quadruplex ligand
SYUIQ-5 induces autophagy by inhibiting the Akt-FOXO3a
pathway in nasopharyngeal cancer cells]. Ai Zheng 2009; 28:
1049–1053.
CAS  PubMed  Google Scholar 
33. Mukherjee S, Ray D, Lekli I, Bak I, Tosaki A, Das DK . Effects
of Longevinex (modified resveratrol) on cardioprotection and
its mechanisms of action. Can J Physiol Pharmacol 2010; 88:
1017–1025.
Article  CAS  PubMed  Google Scholar 
34. Ganley IG, Wong PM, Gammoh N, Jiang X . Distinct
autophagosomal–lysosomal fusion mechanism revealed by
thapsigargin-induced autophagy arrest. Mol Cell 2011; 42:
731–743.
Article  CAS  PubMed Central  PubMed  Google Scholar 
35. Yang JY, Hung MC . Deciphering the role of forkhead
transcription factors in cancer therapy. Curr Drug Targets
2011; 12: 1284–1290.
Article  CAS  PubMed Central  PubMed  Google Scholar 
36. Lu M, Zhao Y, Xu F, Wang Y, Xiang J, Chen D . The
expression and prognosis of FOXO3a and Skp2 in human
ovarian cancer. Med Oncol 2012; 29: 3409–3415.


Article  CAS  PubMed  Google Scholar 
37. Wu X, Liang L, Dong L, Yu Z, Fu X . Effect of ARHI on lung
cancer cell proliferation, apoptosis and invasion in vitro. Mol
Biol Rep 2012; 40: 2671–2678.
Article  PubMed  Google Scholar 
38. Field JK, Liloglou T, Warrak S, Burger M, Becker E, Berlin K
et al. Methylation discriminators in NSCLC identified by a
microarray based approach. Int J Oncol 2005; 27: 105–111.
CAS  PubMed  Google Scholar 
39. Li Y, Shi L, Han C, Wang Y, Yang J, Cao C et al. Effects of
ARHI on cell cycle progression and apoptosis levels of breast
cancer cells. Tumour Biol 2012; 33: 1403–1410.
Article  CAS  PubMed  Google Scholar 
40. Chen MY, Liao WS, Lu Z, Bornmann WG, Hennessey V,
Washington MN et al. Decitabine and suberoylanilide
hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell
lines and xenografts while inducing expression of imprinted
tumor suppressor genes, apoptosis, G2/M arrest, and
autophagy. Cancer 2011; 117: 4424–4438.
Article  CAS  PubMed  Google Scholar 
41. Janssen EA, Ovestad IT, Skaland I, Soiland H, Gudlaugsson E,
Kjellevold KH et al. LOH at 1p31 (ARHI) and proliferation in
lymph node-negative breast cancer. Cell Oncol 2009; 31: 335–
343.
CAS  PubMed  PubMed Central  Google Scholar 
42. Chen Y, Zaman MS, Deng G, Majid S, Saini S, Liu J et al.
MicroRNAs 221/222 and genistein-mediated regulation of
ARHI tumor suppressor gene in prostate cancer. Cancer Prev
Res (Phila) 2011; 4: 76–86.
Article  CAS  Google Scholar 


43. Wang Y, Yu Q, Cho AH, Rondeau G, Welsh J, Adamson E et
al. Survey of differentially methylated promoters in prostate
cancer cell lines. Neoplasia 2005; 7: 748–760.
Article  CAS  PubMed Central  PubMed  Google Scholar 
44. Hu YQ, Si LJ, Ye ZS, Lin ZH, Zhou JP . Inhibitory effect of
ARHI on pancreatic cancer cells and NF-kappaB activity. Mol
Med Rep 2013; 7: 1180–1184.
Article  CAS  PubMed  Google Scholar 
45. Yang H, Lu X, Qian J, Xu F, Hu Y, Yu Y et al. Imprinted tumor
suppressor gene ARHI induces apoptosis correlated with
changes in DNA methylation in pancreatic cancer cells. Mol
Med Rep 2010; 3: 581–587.
PubMed  Google Scholar 
46. Weber F, Aldred MA, Morrison CD, Plass C, Frilling A,
Broelsch CE et al. Silencing of the maternally imprinted tumor
suppressor ARHI contributes to follicular thyroid
carcinogenesis. J Clin Endocrinol Metab 2005; 90: 1149–1155.
Article  CAS  PubMed  Google Scholar 
47. Badgwell DB, Lu Z, Le K, Gao F, Yang M, Suh GK et al. The
tumor-suppressor gene ARHI (DIRAS3) suppresses ovarian
cancer cell migration through inhibition of the Stat3 and
FAK/Rho signaling pathways. Oncogene 2011; 31: 68–79.
Article  PubMed Central  PubMed  Google Scholar 
48. Voigt W . Sulforhodamine B assay and chemosensitivity.
Methods Mol Med 2005; 110: 39–48.
CAS  PubMed  Google Scholar 
Download references


Acknowledgements
These studies were supported in part by grants from the National
Cancer Institute P01 CA064602 and R01 CA135354, by the MD
Anderson SPORE in Ovarian Cancer NCI P50 CA83639, the Shared
Resources of the MD Anderson CCSG NCI P30 CA16672, the
Ovarian Cancer Research Fund, the National Foundation for Cancer
Research and philanthropic support from the Zarrow Foundation
and Stuart and Gaye Lynn Zarrow.
Author information
Author notes
1. W S-L Liao and R C Bast: These authors contributed equally to
this work.
Authors and Affiliations
1. Department of Experimental Therapeutics, The University of
Texas MD Anderson Cancer Center, Houston, 77030-1439,
TX, USA
Z Lu, H Yang, M N Sutton, M Yang, C H Clarke, W S-L
Liao & R C Bast Jr
Authors
1. Z Lu
View author publications
Search author on:PubMed Google Scholar
2. H Yang
View author publications
Search author on:PubMed Google Scholar
3. M N Sutton


View author publications
Search author on:PubMed Google Scholar
4. M Yang
View author publications
Search author on:PubMed Google Scholar
5. C H Clarke
View author publications
Search author on:PubMed Google Scholar
6. W S-L Liao
View author publications
Search author on:PubMed Google Scholar
7. R C Bast Jr
View author publications
Search author on:PubMed Google Scholar
Corresponding author
Correspondence to R C Bast Jr.
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Edited by M Piacentini
Supplementary Information accompanies this paper on Cell Death


and Differentiation website
Supplementary information
Supplementary Information (DOC 550 kb)
Rights and permissions
Reprints and permissions
About this article
[image]
Cite this article
Lu, Z., Yang, H., Sutton, M. et al. ARHI (DIRAS3) induces autophagy
in ovarian cancer cells by downregulating the epidermal growth
factor receptor, inhibiting PI3K and Ras/MAP signaling and
activating the FOXo3a-mediated induction of Rab7. Cell Death Differ
21, 1275–1289 (2014). https://doi.org/10.1038/cdd.2014.48
Download citation
•  Received: 06 June 2013
•  Revised: 10 March 2014
•  Accepted: 11 March 2014
•  Published: 25 April 2014
•  Issue date: August 2014
•  DOI: https://doi.org/10.1038/cdd.2014.48


Share this article
Anyone you share the following link with will be able to read this
content:
Get shareable link
Sorry, a shareable link is not currently available for this article.
Copy shareable link to clipboard
Provided by the Springer Nature SharedIt content-sharing initiative
This article is cited by
•  Differential effects of the LncRNA RNF157-AS1
on epithelial ovarian cancer cells through
suppression of DIRAS3- and ULK1-mediated
autophagy
○  Pengfei Xu
○  Sujuan Xu
○  Xuemei Jia
Cell Death & Disease (2023)
•  Silencing of DIRAS3 improves the proliferation
and insulin secretion of palmitic acid-treated
pancreatic β‑cells through regulating PI3K/AKT
signaling
○  Ying Li
○  Shan Gao
○  Gang Yin
International Journal of Diabetes in Developing Countries (2023)


•  Autophagy, molecular chaperones, and unfolded
protein response as promoters of tumor
recurrence
○  Bashar Alhasan
○  Marina Mikeladze
○  Boris Margulis
Cancer and Metastasis Reviews (2023)
•  Downregulation of the ubiquitin ligase KBTBD8
prevented epithelial ovarian cancer progression
○  Lei Du
○  Cong-Rong Li
○  Xiao-Wei Xing
Molecular Medicine (2020)
•  Oncogenic Ras is downregulated by ARHI and
induces autophagy by Ras/AKT/mTOR pathway
in glioblastoma
○  Chen Zhong
○  Mengting Shu
○  Shiguang Zhao
BMC Cancer (2019)
Associated content
Collection
Webfocus on Autophagy
Advertisement


[image]
Explore content
•  Research articles
•  Reviews & Analysis
•  News & Comment
•  Videos
•  Current issue
•  Collections
•  Follow us on Twitter
•  Subscribe
•  Sign up for alerts
•  RSS feed
About the journal
•  Journal Information
•  About the Editors
•  Open access publishing
•  About the Partner
•  Contact
•  Special Issues
•  For Advertisers
•  Subscribe
•  Upcoming Conferences
Publish with us
•  For Authors & Referees
•  Language editing services
•  Open access funding


•  Submit manuscript
Search
Search articles by subject, keyword or author
Show results from All journals This journal
Search
Advanced search
Quick links
•  Explore articles by subject
•  Find a job
•  Guide to authors
•  Editorial policies
Cell Death & Differentiation (Cell Death Differ)
ISSN 1476-5403 (online)
ISSN 1350-9047 (print)
nature.com sitemap
About Nature Portfolio
•  About us
•  Press releases
•  Press office
•  Contact us
Discover content
•  Journals A-Z
•  Articles by subject
•  protocols.io
•  Nature Index


Publishing policies
•  Nature portfolio policies
•  Open access
Author & Researcher services
•  Reprints & permissions
•  Research data
•  Language editing
•  Scientific editing
•  Nature Masterclasses
•  Research Solutions
Libraries & institutions
•  Librarian service & tools
•  Librarian portal
•  Open research
•  Recommend to library
Advertising & partnerships
•  Advertising
•  Partnerships & Services
•  Media kits
•  Branded content
Professional development
•  Nature Awards
•  Nature Careers
•  Nature Conferences
Regional websites
•  Nature Africa
•  Nature China
•  Nature India


•  Nature Japan
•  Nature Middle East
•  Privacy Policy
•  Use of cookies
•  Your privacy choices/Manage cookies
•  Legal notice
•  Accessibility statement
•  Terms & Conditions
•  Your US state privacy rights
[image]
© 2025 Springer Nature Limited


[image]


